145 related articles for article (PubMed ID: 12838271)
1. Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Neuropsychopharmacology; 2003 Aug; 28(8):1433-9. PubMed ID: 12838271
[TBL] [Abstract][Full Text] [Related]
2. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Psychopharmacology (Berl); 2003 Jan; 165(2):166-71. PubMed ID: 12417967
[TBL] [Abstract][Full Text] [Related]
3. Continuous but not intermittent olanzapine infusion induces vacuous chewing movements in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Biol Psychiatry; 2005 Feb; 57(4):406-11. PubMed ID: 15705357
[TBL] [Abstract][Full Text] [Related]
4. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
5. Autoradiographic mapping of mu opioid receptor changes in rat brain after long-term haloperidol treatment: relationship to the development of vacuous chewing movements.
Sasaki T; Kennedy JL; Nobrega JN
Psychopharmacology (Berl); 1996 Nov; 128(1):97-104. PubMed ID: 8944412
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of EGb761 and vitamin E on haloperidol-induced vacuous chewing movements in rats: Possible involvement of S100B mechanisms.
An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Lv MH; Zhou DF; Soares JC; Kosten TR; Yang FD; Zhang XY
Behav Brain Res; 2016 Jan; 297():124-30. PubMed ID: 26455874
[TBL] [Abstract][Full Text] [Related]
7. The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?
Turrone P; Remington G; Nobrega JN
Neurosci Biobehav Rev; 2002 May; 26(3):361-80. PubMed ID: 12034136
[TBL] [Abstract][Full Text] [Related]
8. Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia.
Lister J; Andreazza AC; Navaid B; Wilson VS; Teo C; Nesarajah Y; Wilson AA; Nobrega JN; Fletcher PJ; Remington G
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():23-29. PubMed ID: 27565433
[TBL] [Abstract][Full Text] [Related]
9. Differential role of dopamine D1 and D2 receptors in isoniazid-induced vacuous chewing movements.
Naidu PS; Kulkarni SK
Methods Find Exp Clin Pharmacol; 2000 Dec; 22(10):747-51. PubMed ID: 11346896
[TBL] [Abstract][Full Text] [Related]
10. Parallels between behavioral and neurochemical variability in the rat vacuous chewing movement model of tardive dyskinesia.
Bachus SE; Yang E; McCloskey SS; Minton JN
Behav Brain Res; 2012 Jun; 231(2):323-36. PubMed ID: 22503783
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
Egan MF; Hurd Y; Ferguson J; Bachus SE; Hamid EH; Hyde TM
Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
[TBL] [Abstract][Full Text] [Related]
12. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
Naidu PS; Kulkarni SK
Behav Pharmacol; 2001 Jun; 12(3):209-16. PubMed ID: 11485057
[TBL] [Abstract][Full Text] [Related]
13. D2-receptor upregulation is dependent upon temporal course of D2-occupancy: a longitudinal [11C]-raclopride PET study in cats.
Ginovart N; Wilson AA; Hussey D; Houle S; Kapur S
Neuropsychopharmacology; 2009 Feb; 34(3):662-71. PubMed ID: 18688210
[TBL] [Abstract][Full Text] [Related]
14. Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery.
Samaha AN; Reckless GE; Seeman P; Diwan M; Nobrega JN; Kapur S
Biol Psychiatry; 2008 Jul; 64(2):145-52. PubMed ID: 18295747
[TBL] [Abstract][Full Text] [Related]
15. Early gene mapping after deep brain stimulation in a rat model of tardive dyskinesia: comparison with transient local inactivation.
Creed MC; Hamani C; Nobrega JN
Eur Neuropsychopharmacol; 2012 Jul; 22(7):506-17. PubMed ID: 22153973
[TBL] [Abstract][Full Text] [Related]
16. Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.
De Souza IE; Dawson NM; Clifford JJ; Waddington JL; Meredith GE
Psychopharmacology (Berl); 2003 Aug; 169(1):28-34. PubMed ID: 12830366
[TBL] [Abstract][Full Text] [Related]
17. Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements.
Knable MB; Hyde TM; Egan MF; Tosayali M; Wyatt RJ; Kleinman JE
Brain Res; 1994 May; 646(2):217-22. PubMed ID: 8069667
[TBL] [Abstract][Full Text] [Related]
18. Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.
Bordia T; Zhang D; Perez XA; Quik M
Exp Neurol; 2016 Dec; 286():32-39. PubMed ID: 27658674
[TBL] [Abstract][Full Text] [Related]
19. Anandamide attenuates haloperidol-induced vacuous chewing movements in rats.
Röpke J; Busanello A; Leal CQ; de Moraes Reis E; de Freitas CM; Villarinho JG; Figueira FH; Mello CF; Ferreira J; Fachinetto R
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():195-9. PubMed ID: 24747871
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol versus risperidone on rat "early onset" vacuous chewing.
Marchese G; Bartholini F; Casu MA; Ruiu S; Casti P; Congeddu E; Tambaro S; Pani L
Behav Brain Res; 2004 Feb; 149(1):9-16. PubMed ID: 14739005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
